Solid Biosciences Inc.SLDBNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-157.44M
↓ 89% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-83.24M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-157.44M | -56.4% |
| 2024 | $-100.67M | -5.2% |
| 2023 | $-95.69M | +5.2% |
| 2022 | $-100.99M | -27.8% |
| 2021 | $-79.05M | -37.5% |
| 2020 | $-57.50M | +40.8% |
| 2019 | $-97.10M | -24.5% |
| 2018 | $-77.97M | -71.4% |
| 2017 | $-45.50M | -121.8% |
| 2016 | $-20.51M | - |